Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.
NHS cataract surgery and YAG laser capsulotomy patients will benefit from high-quality care and significantly reduced waiting times at new SpaMedica hospital.
Blind and partially sighted Glasgow residents will be able to get in-person support and advice at their local library, thanks to new sessions organised by a national sight loss charity.
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
Dr Louise Wood CBE has been appointed as Moorfields Eye Charity’s new chair and will succeed Mervyn Walker when he steps down from the role in July 2024.
1 February 2016
| Fiona Harris, Spyridon Chalkiadakis, Simon Taylor (Prof)
|
Retina / Uvea / Vitreous
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...